Skip to content

Clinical trials

Active, not recruiting Lymphoma, Large B-Cell, Diffuse trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Status: Active, not recruiting Country / region: China Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20191
20204
20211
20224
20234
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Genmab4
Hoffmann-La Roche2
ADC Therapeutics S.A.1
Acerta Pharma BV1
Cancer Institute and Hospital, Chinese Academy of Medical Sciences1
Cothera Bioscience, Inc1
Janssen Research & Development, LLC1
Karyopharm Therapeutics Inc1
Regeneron Pharmaceuticals1
Ruijin Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse19
Lymphoma, Non-Hodgkin4
Recurrence4
Lymphoma, B-Cell3
Lymphoma, Follicular3
Neoplasms3
Lymphatic Diseases2
Lymphoma2
Lymphoma, Mantle-Cell2
Bronchiolitis Obliterans Syndrome1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.